TITLE

CELL BIOLOGY - IMMUNOLOGY - PATHOLOGY The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation

AUTHOR(S)
Cheung, Catherine W.; Vesey, David A.; Nicol, David L.; Johnson, David W.
PUB. DATE
April 2004
SOURCE
Kidney International;Apr2004, Vol. 65 Issue 4, p1272
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The roles of IGF-I and IGFBP -3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. Background. Insulin-like growth factor I (IGF-I), a potent proximal tubule cell (PTC) mitogen, has been implicated in the progression of many human cancers. Our previous work on human renal tissues has suggested that IGF-I and several of its binding proteins (IGFBP-3 and -6) are up-regulated in clear cell renal cell carcinoma (RCC). Methods. To further elucidate the role of IGF-I and IGFBPs in RCC growth, immunohistochemistry, thymidine incorporation, and Western analysis were performed in primary cultures of normal PTC (priPTC) and clear-cell RCC (priRCC), as well as in SN12K1 cells (a cell line derived from metastatic RCC). Results. By immunohistochemistry, IGFBP-3 and IGF-I were prominently expressed in SN12K1 cells, and weakly expressed in priPTC and priRCC. Incubation with 100 ng/mL IGF-I significantly augmented DNA synthesis by priPTC (mean ± SD 120.7%± 19.7% of controls, P < 0.05), priRCC (238.7%± 279.9% of controls, P < 0.01), and SN12K1(120.0%± 22.9% of controls, P < 0.05). Neutralizing antibodies to IGF-I and IGF-I receptor significantly suppressed SN12K1 growth (81.9%± 13.5% of control, P < 0.01 and 87.4%± 16.2% of control, P < 0.05, respectively). Removal of endogenous IGFBP-3 by an anti-IGFBP-3 increased SN12K1 DNA synthesis (243.9%± 35.3% of control, P < 0.001), which was partially abrogated by coincubation with exogenous IGFBP-3 (135.97%± 5.9% of controls, P < 0.001). Using Western analysis, IGFBP-3 expression was enhanced in IGF-I–stimulated SN12K1 cells exposed to exogenous IGF-I. Coincubation with anti-IGFBP-3 further enhanced IGF-I–induced DNA synthesis. Conclusion. RCC cells express IGF-I and IGFBP-3, and are responsive to exogenous IGF-I stimulation. Moreover, in SN12K1 cells (derived from metastatic RCC), autocrine IGF-I and IGFBP-3 actions, respectively, stimulated and inhibited growth. These results suggest that IGF-I and IGFBP-3 may be potential candidates for therapeutic manipulation in patients with advanced RCC.
ACCESSION #
12472432

 

Related Articles

  • Overexpression of SATB1 Is Associated with Biologic Behavior in Human Renal Cell Carcinoma. Cheng, Chao; Wan, Feng; Liu, Lian; Zeng, Fuqing; Xing, Shi'an; Wu, Xiaofei; Chen, Xuepan; Zhu, Zhaohui // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Special AT-rich sequence-binding protein-1 (SATB1) has been reported to be aberrantly expressed in various cancers and correlated with the malignant behavior of cancer cells. However, the function of SATB1 in RCC remains unclear. With the combination of immunohistochemistry, western blotting,...

  • Imprint cytology of the chromophobe renal cell carcinoma: Correlation with the histological and ultrastructural features. WONAE LEE // Journal of Cytology;Apr-Jun2011, Vol. 28 Issue 2, p77 

    Chromophobe renal cell carcinoma (ChRCC) is a unique entity of renal cell carcinoma and has a low malignant potential. A correct cytological diagnosis can help to decide the suitable management and operation. I present here a case with an imprint cytology of ChRCC focusing on the correlation...

  • Elevated Expression of Stromal Palladin Predicts Poor Clinical Outcome in Renal Cell Carcinoma. Gupta, Vivekanand; Bassi, Daniel E.; Simons, Jeffrey D.; Devarajan, Karthik; Al-Saleem, Tahseen; Uzzo, Robert G.; Cukierman, Edna // PLoS ONE;2011, Vol. 6 Issue 6, p1 

    The role that stromal renal cell carcinoma (RCC) plays in support of tumor progression is unclear. Here we sought to determine the predictive value on patient survival of several markers of stromal activation and the feasibility of a fibroblastderived extracellular matrix (ECM) based...

  • Transformation capacities of the papillary renal cell carcinoma-associated PRCCTFE3 and TFE3PRCC fusion genes. Weterman, Marian A J; van Groningen, Jan J M; den Hartog, Anita; Geurts van Kessel, Ad // Oncogene;3/22/2001, Vol. 20 Issue 12, p1414 

    A recurrent chromosomal abnormality associated with a subset of papillary renal cell carcinomas is t(X;1)(p11;q21). This translocation leads to the formation of two fusion genes, TFE3PRCC and the reciprocal product PRCCTFE3. Both fusion genes are expressed in t(X;1)-positive renal cell...

  • Gene therapy for renal cell cancer looks promising. Newman, Laura // Urology Times;Sep96, Vol. 24 Issue 9, p18 

    Focuses on gene therapy for renal cell cancer. Financial aspects; Mechanism of action; Results on patients; Expectations.

  • Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Stassar, M J J G; Devitt, G; Brosius, M; Rinnab, L; Prang, J; Schradin, T; Simon, J; Petersen, S; Kopp-Schneider, A; Zöller, M // British Journal of Cancer;11/1/2001, Vol. 85 Issue 9, p1372 

    Renal cell carcinoma (RCC) are frequently chemo- and radiation resistant. Thus, there is a need for identifying biological features of these cells that could serve as alternative therapeutic targets. We performed suppression subtractive hybridization (SSH) on patient-matched normal renal and RCC...

  • Expression of FTL and FTH genes encoding ferritin subunits in lung and renal carcinomas. Kudriavtseva, A. V.; Anedchenko, E. A.; Oparina, N. Yu.; Krasnov, G. S.; Kashkin, K. N.; Dmitriev, A. A.; Zborovskaya, I. B.; Kondratjeva, T. T.; Vinogradova, E. V.; Zinovyeva, M. V.; Kopantsev, E. P.; Senchenko, V. N. // Molecular Biology;Dec2009, Vol. 43 Issue 6, p972 

    Numerous human cancers are accompanied with the increase of ferritin content in blood serum. Ferritin is composed of light and heavy chains, encoded by FTL and FTH genes, respectively. The analysis of EST database showed that the expression of FTL and FTH genes in lung tumors is decreased...

  • Role of the RNA-binding protein HuR in human renal cell carcinoma. Danilin, Sabrina; Sourbier, Carole; Thomas, Lionel; Lindner, Véronique; Rothhut, Sylvie; Dormoy, Valérian; Helwig, Jean-Jacques; Jacqmin, Didier; Lang, Hervé; Massfelder, Thierry // Carcinogenesis;Jun2010, Vol. 31 Issue 6, p1018 

    Human conventional renal cell carcinoma (CRCC) remains resistant to therapy. The RNA-binding protein HuR regulates the stability and/or translation of multiple messenger RNAs involved in malignant transformation. In this study, we aimed to evaluate the potential role of HuR in this pathology....

  • Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities. Graves, Angela; Hessamodini, Hannah; Germaine Wong; Lim, Wai H. // ImmunoTargets & Therapy;2013, Vol. 2, p73 

    The treatment of advanced renal cell carcinoma (RCC) remains a major therapeutic challenge for clinicians. Despite advances in the understanding of the immunobiology of RCC and the availability of several novel targeted agents, there has been little improvement in the survival of patients with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics